Search research articles
Contact Us
Filters
Showing results (621-630 of 639) with videos related to
Page
of 64
Sort By:
Experimental Parasitology
|
June 25, 2025
Urine- and serum-based ELISA using a new recombinant chimeric protein to diagnose tegumentary and visceral leishmaniasis: a preliminary study
Raquel S B Câmara, Ana L Silva, Camila S Freitas, et al.
Microbial Pathogenesis
|
May 5, 2022
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasis
Danniele L Vale, Amanda S Machado, Fernanda F Ramos, et al.
Microbial Pathogenesis
|
August 4, 2022
Anti-inflammatory effect, antibiotic potentiating activity against multidrug-resistant strains of Escherichia coli and Staphylococcus aureus, and evaluation of antibiotic resistance mechanisms by the ibuprofen derivative methyl 2-(-4-isobutylphenyl)propanoate
Maria R Xavier, Thiago S Freitas, Raimundo L S Pereira, et al.
Parasite (Paris, France)
|
May 1, 2020
A clioquinol-containing Pluronic<sup>®</sup> F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model
Grasiele S V Tavares, Débora V C Mendonça, Isabela A G Pereira, et al.
Diagnostic Microbiology and Infectious Disease
|
May 8, 2024
A recombinant chimeric antigen constructed with B-cell epitopes from Mycobacterium leprae hypothetical proteins is effective for the diagnosis of leprosy
Bárbara P N Assis, Ana T Chaves, Daniela P Lage, et al.
Experimental Parasitology
|
December 30, 2021
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study
Débora V C Mendonça, Grasiele S V Tavares, Isabela A G Pereira, et al.
ACS Omega
|
April 27, 2026
Enhanced Antiviral Activity of Novel Umifenovir Derivatives against SARS-CoV-2: Insights from an International Collaborative Study
Melina Mottin, Christopher D Jurisch, Sabrina Silva-Mendonça, et al.
Acta Tropica
|
September 19, 2021
Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary study
Thaís T O Santos, Fernanda F Ramos, Isabela A P Gonçalves, et al.
Cellular Immunology
|
April 8, 2025
A new chimeric protein composed by T-cell epitopes from peroxidoxin and pyridoxal kinase proteins is protective against visceral leishmaniasis
Daniela P Lage, Danniele L Vale, Marcela G P Silva, et al.
Diagnostic Microbiology and Infectious Disease
|
December 5, 2024
Urine and serum-based ELISA using a recombinant protein and synthetic peptide for the diagnosis of tegumentary leishmaniasis
Camila S Freitas, Raquel S B Câmara, Daniela P Lage, et al.
Page
of 64
Search research articles
Search
Showing results (621-630 of 639) with videos related to
Sort By:
Page
of 64
Experimental Parasitology
|
June 25, 2025
Urine- and serum-based ELISA using a new recombinant chimeric protein to diagnose tegumentary and visceral leishmaniasis: a preliminary study
Raquel S B Câmara, Ana L Silva, Camila S Freitas, et al.
Microbial Pathogenesis
|
May 5, 2022
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasis
Danniele L Vale, Amanda S Machado, Fernanda F Ramos, et al.
Microbial Pathogenesis
|
August 4, 2022
Anti-inflammatory effect, antibiotic potentiating activity against multidrug-resistant strains of Escherichia coli and Staphylococcus aureus, and evaluation of antibiotic resistance mechanisms by the ibuprofen derivative methyl 2-(-4-isobutylphenyl)propanoate
Maria R Xavier, Thiago S Freitas, Raimundo L S Pereira, et al.
Parasite (Paris, France)
|
May 1, 2020
A clioquinol-containing Pluronic<sup>®</sup> F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model
Grasiele S V Tavares, Débora V C Mendonça, Isabela A G Pereira, et al.
Diagnostic Microbiology and Infectious Disease
|
May 8, 2024
A recombinant chimeric antigen constructed with B-cell epitopes from Mycobacterium leprae hypothetical proteins is effective for the diagnosis of leprosy
Bárbara P N Assis, Ana T Chaves, Daniela P Lage, et al.
Experimental Parasitology
|
December 30, 2021
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study
Débora V C Mendonça, Grasiele S V Tavares, Isabela A G Pereira, et al.
ACS Omega
|
April 27, 2026
Enhanced Antiviral Activity of Novel Umifenovir Derivatives against SARS-CoV-2: Insights from an International Collaborative Study
Melina Mottin, Christopher D Jurisch, Sabrina Silva-Mendonça, et al.
Acta Tropica
|
September 19, 2021
Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary study
Thaís T O Santos, Fernanda F Ramos, Isabela A P Gonçalves, et al.
Cellular Immunology
|
April 8, 2025
A new chimeric protein composed by T-cell epitopes from peroxidoxin and pyridoxal kinase proteins is protective against visceral leishmaniasis
Daniela P Lage, Danniele L Vale, Marcela G P Silva, et al.
Diagnostic Microbiology and Infectious Disease
|
December 5, 2024
Urine and serum-based ELISA using a recombinant protein and synthetic peptide for the diagnosis of tegumentary leishmaniasis
Camila S Freitas, Raquel S B Câmara, Daniela P Lage, et al.
Page
of 64